Health Information
Nephrology (Kidney Disease)
Research
Nephrology research at Morgan Stanley Children's Hospital of NewYork-Presbyterian is committed to furthering the understanding of renal disease and expanding and improving its therapies.
Our nephrologists have completed a study of the effects of growth hormone on body composition and growth in children with chronic renal failure. They are also investigating
- a new drug to treat high blood pressure in children with hypertension and kidney disease;
- the use of a standardized questionnaire - in collaboration with Johns Hopkins Hospital - to assess the perceived health status and quality of life for adolescents with renal failure;
- the use of a drug - mycophenolate mofetil - in children with nephrotic syndrome who are experiencing side effects from standard steroid therapy (part of a collaborative study with the Southwest Pediatric Nephrology Study Group);
- the effectiveness of a new form of erythropoietin - a hormone produced by the kidney that promotes the formation of red blood cells in the bone marrow - to treat children with anemia caused by chronic kidney failure;
- TGF-beta and progression of renal disease;
- the effect of mycophenolate mofetil on progression of renal disease in patient with obstructive uropathy;
- the use of intravenous immunoglobulin in the treatment of membranoproliferative glomerulonephritis.
The nephrology program at Morgan Stanley Children's Hospital is part of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), which conducts important research and data collection for children with chronic renal failure and those on dialysis or who have had a transplantation.
